tiprankstipranks
Trending News
More News >
Newron Pharmaceuticals SpA (CH:NWRN)
:NWRN
Switzerland Market

Newron Pharmaceuticals SpA (NWRN) Income Statement

Compare
2 Followers

Newron Pharmaceuticals SpA Income Statement

Last quarter (Q2 2025), Newron Pharmaceuticals SpA's total revenue was €11.90M, an increase of 116.56% from the same quarter last year. In Q2, Newron Pharmaceuticals SpA's net income was €-73.00K. See Newron Pharmaceuticals SpA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 51.39M€ 9.06M€ 6.09M€ 5.76M€ 5.26M
Gross Profit
€ 51.39M€ 9.06M€ 6.09M€ 5.76M€ 4.96M
Operating Expenses
€ 25.22M€ 20.69M€ 19.40M€ 18.12M€ 23.32M
Depreciation and Amortization
€ 192.00K€ 201.00K€ 202.00K€ 47.00K€ 72.00K
EBITDA
€ 25.94M€ -11.83M€ -13.32M€ -11.92M€ -17.99M
Operating Income
€ 26.17M€ -11.63M€ -13.30M€ -12.36M€ -18.07M
Other Income/Expenses
€ -4.78M€ -4.57M€ -4.17M€ -2.53M€ -1.55M
Pretax Income
€ 21.39M€ -16.20M€ -17.47M€ -14.88M€ -19.62M
Net Income
€ 15.84M€ -16.22M€ -17.49M€ -14.90M€ -21.00M
Per Share Metrics
Basic EPS
€ 0.85€ -0.91€ -0.98€ -0.84€ -1.18
Diluted EPS
€ 0.85€ -0.91€ -0.98€ -0.84€ -1.18
Weighted Average Shares Outstanding
18.56M 17.84M 17.84M 17.84M 17.84M
Weighted Average Shares Outstanding (Diluted)
18.56M 17.84M 17.84M 17.84M 17.84M
Currency in EUR

Newron Pharmaceuticals SpA Earnings and Revenue History